HYDERABAD: Dr Reddy's Laboratories has received the Drug Controller General of India ( DCGI) to conduct Phase III trials of Russian Covid-19 vaccine Sputnik V in India, the company informed the bourses on Friday. "The Phase III study of Sputnik V will be conducted on 1500 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India," Dr Reddy's said is a late night regulatory filing.
Go deeper (2 min. read) →
FAQ
Watch Live TV News
Younews is India's best trending news aggregator. We help you discover latest trending content and the most popular stories from all sites across India. Add Younews to your home screen for easy, fast access to latest trending news. Use the 3-dot menu of your browser app and click "Install/add to home screen".
LUV
SAD
WOW
MEH
GRR
HUH
LOL
0
0
0
0
0
0
0
This story is trending. Share it.
Loading...
